Tesamorelin 10mg

Tesamorelin – 10mg

GHRH Analog • Lyophilized Peptide • Research Use Only

Description: Tesamorelin is a synthetic Growth Hormone‑Releasing Hormone (GHRH) analog engineered to stimulate endogenous growth hormone (GH) secretion. It is widely studied for its effects on lipolysis, visceral fat metabolism, and overall metabolic health. Research models frequently explore Tesamorelin’s ability to enhance GH‑mediated fat reduction, improve body composition, and support healthy aging.

Tesamorelin is of particular interest in studies involving growth hormone deficiency, visceral adiposity, insulin sensitivity, and cardiovascular risk markers, making it a central compound in metabolic and endocrine research.

Specifications

• Peptide: Tesamorelin (GHRH analog)

• Purity: ≥99.8%

• Form: Lyophilized powder

• Quantity: 10mg per vial

• Storage:

  • Store at –20°C (–4°F)

  • After reconstitution, refrigerate at 2–8°C (36–46°F); use within 30 days

• Grade: Research Use Only — Not for human consumption, therapeutic, or diagnostic applications

Research Focus Areas

• Growth hormone secretion and GH‑axis activation

• Lipolysis and visceral‑fat metabolism

• Body composition and anti‑aging studies

• Metabolic health, insulin sensitivity, and glucose regulation

• Cardiovascular risk‑marker investigations

Mechanistic Interest

Tesamorelin is studied for its ability to:

• Stimulate endogenous GH release through GHRH receptor activation

• Enhance lipolysis, particularly in visceral adipose tissue

• Improve metabolic efficiency and body‑composition markers

• Support IGF‑1 signaling and anabolic pathways

• Influence cardiometabolic health in research models

Its targeted metabolic and endocrine activity makes Tesamorelin a leading peptide in GH‑axis, fat‑metabolism, and longevity‑research applications.

NOTICE

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.